1. Longitudinal registration of T 1 -weighted breast MRI: A registration algorithm (FLIRE) and clinical application.
- Author
-
Tong MW, Yu HJ, Sjaastad Andreassen MM, Loubrie S, Rodríguez-Soto AE, Seibert TM, Rakow-Penner R, and Dale AM
- Subjects
- Humans, Female, Middle Aged, Longitudinal Studies, Neoadjuvant Therapy, Image Interpretation, Computer-Assisted methods, Reproducibility of Results, Adult, Image Processing, Computer-Assisted methods, Aged, Software, Algorithms, Breast Neoplasms diagnostic imaging, Breast Neoplasms drug therapy, Magnetic Resonance Imaging methods, Breast diagnostic imaging
- Abstract
Purpose: MRI is commonly used to aid breast cancer diagnosis and treatment evaluation. For patients with breast cancer, neoadjuvant chemotherapy aims to reduce the tumor size and extent of surgery necessary. The current clinical standard to measure breast tumor response on MRI uses the longest tumor diameter. Radiologists also account for other tissue properties including tumor contrast or pharmacokinetics in their assessment. Accurate longitudinal image registration of breast tissue is critical to properly compare response to treatment at different timepoints., Methods: In this study, a deformable Fast Longitudinal Image Registration (FLIRE) algorithm was optimized for breast tissue. FLIRE was then compared to the publicly available software packages with high accuracy (DRAMMS) and fast runtime (Elastix). Patients included in the study received longitudinal T
1 - weighted MRI without fat saturation at two to six timepoints as part of asymptomatic screening (n = 27) or throughout neoadjuvant chemotherapy treatment (n = 32). T1 - weighted images were registered to the first timepoint with each algorithm., Results: Alignment and runtime performance were compared using two-way repeated measure ANOVAs (P < 0.05). Across all patients, Pearson's correlation coefficient across the entire image volume was slightly higher with statistical significance and had less variance for FLIRE (0.98 ± 0.01 stdev) compared to DRAMMS (0.97 ± 0.03 stdev) and Elastix (0.95 ± 0.03 stdev). Additionally, FLIRE runtime (10.0 mins) was 9.0 times faster than DRAMMS (89.6 mins) and 1.5 times faster than Elastix (14.5 mins) on a Linux workstation., Conclusion: FLIRE demonstrates promise for time-sensitive clinical applications due to its accuracy, robustness across patients and timepoints, and speed., Competing Interests: Declaration of competing interest Dr. Anders Dale is a Founder of and holds equity in CorTechs Labs, Inc., and serves on its Scientific Advisory Board. He is a member of the Scientific Advisory Board of Human Longevity, Inc. He receives funding through research grants from GE Healthcare to the University of California San Diego (UCSD). Similarly, Dr. Rebecca Rakow-Penner is a consultant for Human Longevity, Inc. She also receives funding through research grants from GE Healthcare to UCSD. She also has equity interest in CorTechs Labs and serves on its Scientific Advisory Board. She has stock options in CureMetrix. She is also on the Scientific Advisory board for Imagine Scientific. She reports honoraria from Bayer and consulted for Bayer. Dr. Tyler Seibert reports honoraria from Varian Medical Systems and WebMD; he has an equity interest in CorTechs Labs and serves on its Scientific Advisory Board. He also receives in-kind research support from GE Healthcare through agreements between GE Healthcare and UCSD., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF